Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic...(atment ofpsoriasis than psoriatic arthri...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis
Date:9/10/2007
atment of psoriasis than psoriatic arthritis.
Psoriasis and Psoriatic Arthritis: The Expanding Biologics Landscape is based on a U.S. survey of 50 dermatologists, 51 rheumatologists and 20 managed care pharmacy directors. Their responses were compared to assess similarities and differences of opinion regarding clinical and economic, factors in the management of psoriasis and Psoriatic arthritis with biologic therapies.
About Physician & Payer Forum
Physician & Payer Forum is a primary research service from Decision Resources that offers access to high-volume-prescribing physicians, specialists, and managed care organization representatives in the United States; analysis of events and survey participants' responses to them; insight into prescribing patterns; and an examination of the implications of events and issues for the pharmaceutical market.
About Decision Resources
Decision Resources, Inc. (http://www.decisionresources.com) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Elizabeth Marshall
Decision Resources, Inc.
781-296-2563
'/>"/>
| SOURCE Decision Resources Copyright©2007 PR Newswire. All rights reserved |
Related biology technology :
1. Sonic closer to turning profit corner
2. Turning ads into sales: Context is king
3. Turning Around a Sick Company
4. GE Healthcare technology helping to detect Alzheimers earlier
5. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
6. Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns
7. Quintessence cancer treatment chosen for clinical studies
8. ZyStor to exhibit cell disorder treatments
9. Radiology advance points way to non-invasive brain-cancer treatment
10. Animal testing: Beyond the protests, instances of mistreatment are rare
11. TomoTherapy leads the industry in CT image-guided treatments
Post Your Comments:
Breaking Biology Technology:Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 3Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 2Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 3Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 4Reportlinker Adds Pharmacodynamic Assays 2Reportlinker Adds Pharmacodynamic Assays 3Reportlinker Adds Pharmacodynamic Assays 4The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program 2The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program 3
[0] Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas[0] Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit[0] Reportlinker Adds Pharmacodynamic Assays[0] The Pittsburgh Life Sciences Greenhouse Announces Additions to Nationally Recognized Executive Program
Other Biology Technology:AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer 2AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer 3AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer 4Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development 2Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development 3Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development 4Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development 5Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development 6
AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One KillerCatalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and DevelopmentAgendia to Present at BioCentury's Future Leaders in the Biotech Industry Conference
Breaking Biology News(10 mins):Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 3Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 5Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 6Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 7Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 8Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 9Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 10First-in-class treatment for acute leukemia 2First-in-class treatment for acute leukemia 3Study finds new relationship between gene duplication and alternative splicing in plants 2Study finds new relationship between gene duplication and alternative splicing in plants 3Blue Belt Technologies Inc Closes Series A Financing 5111 1Blue Belt Technologies Inc Closes Series A Financing 5111 2Blue Belt Technologies Inc Closes Series A Financing 5111 3Abbott Cuts Use of Oil and Coal by 35 Percent 5108 1Abbott Cuts Use of Oil and Coal by 35 Percent 5108 2Abbott Cuts Use of Oil and Coal by 35 Percent 5108 3Urologists Radiologists Patients Benefit From New Clinical Prostate Visualization System 5105 1Urologists Radiologists Patients Benefit From New Clinical Prostate Visualization System 5105 2
Other Biology News:Hybridization partially restores vision in cavefish, NYU study finds 2Scientific evidence supporting evolution continues to grow 2Scientific evidence supporting evolution continues to grow 3American Chemical Society's weekly PressPac -- Jan. 2, 2008 2American Chemical Society's weekly PressPac -- Jan. 2, 2008 3American Chemical Society's weekly PressPac -- Jan. 2, 2008 4American Chemical Society's weekly PressPac -- Jan. 2, 2008 5American Chemical Society's weekly PressPac -- Jan. 2, 2008 6American Chemical Society's weekly PressPac -- Jan. 2, 2008 7American Chemical Society's weekly PressPac -- Jan. 2, 2008 8American Chemical Society's weekly PressPac -- Jan. 2, 2008 9
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |